Characterization of Diverse Subvariants of the Meningococcal Factor H (fH) Binding Protein for Their Ability To Bind fH, To Mediate Serum Resistance, and To Induce Bactericidal Antibodies
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of Diverse Subvariants of the Meningococcal Factor H (fH) Binding Protein for Their Ability To Bind fH, To Mediate Serum Resistance, and To Induce Bactericidal Antibodies
Authors
Keywords
-
Journal
INFECTION AND IMMUNITY
Volume 79, Issue 2, Pages 970-981
Publisher
American Society for Microbiology
Online
2010-12-14
DOI
10.1128/iai.00891-10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement regulator factor H as a serum biomarker of multiple sclerosis disease state
- (2010) Gillian Ingram et al. BRAIN
- Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine
- (2010) J. Lucidarme et al. Clinical and Vaccine Immunology
- Effect of Factor H-Binding Protein Sequence Variation on Factor H Binding and Survival ofNeisseria meningitidisin Human Blood
- (2010) Kathleen Y. Dunphy et al. INFECTION AND IMMUNITY
- Research and development of universal influenza vaccines
- (2010) Lanying Du et al. MICROBES AND INFECTION
- Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
- (2010) Marzia M. Giuliani et al. VACCINE
- Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
- (2010) Han-Qing Jiang et al. VACCINE
- The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement
- (2010) Lisa A. Lewis et al. PLoS Pathogens
- Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective Activity
- (2009) J. S. Plested et al. Clinical and Vaccine Immunology
- Challenges and progress in the development of a serogroup B meningococcal vaccine
- (2009) Susan Lewis et al. Expert Review of Vaccines
- Functional Comparison of the Binding of Factor H Short Consensus Repeat 6 (SCR 6) to Factor H Binding Protein from Neisseria meningitidis and the Binding of Factor H SCR 18 to 20 to Neisseria gonorrhoeae Porin
- (2009) J. Shaughnessy et al. INFECTION AND IMMUNITY
- Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen ofNeisseria meningitidis
- (2009) Francesca Cantini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup BNeisseria meningitidis
- (2009) Ellen Murphy et al. JOURNAL OF INFECTIOUS DISEASES
- The modular architecture of meningococcal factor H-binding protein
- (2009) P. T. Beernink et al. MICROBIOLOGY-SGM
- Variation of the factor H-binding protein of Neisseria meningitidis
- (2009) C. Brehony et al. MICROBIOLOGY-SGM
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
- (2009) Muriel C. Schneider et al. NATURE
- Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
- (2009) Stefania Bambini et al. VACCINE
- Seroprevalence of antibodies against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis
- (2009) Susanne Jacobsson et al. VACCINE
- Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease
- (2009) Susanne Jacobsson et al. VACCINE
- Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
- (2009) Lisa K. McNeil et al. VACCINE
- Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera
- (2008) D. M. Granoff et al. INFECTION AND IMMUNITY
- Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37
- (2008) K. L. Seib et al. INFECTION AND IMMUNITY
- Complement‐Dependent Synergistic Bactericidal Activity of Antibodies against Factor H–Binding Protein, a Sparsely Distributed Meningococcal Vaccine Antigen
- (2008) Jo Anne Welsch et al. JOURNAL OF INFECTIOUS DISEASES
- Evolving complexities of influenza virus and its receptors
- (2008) John M. Nicholls et al. TRENDS IN MICROBIOLOGY
- Factor H-binding protein, a unique meningococcal vaccine antigen
- (2008) Mariagrazia Pizza et al. VACCINE
- Microbial complement inhibitors as vaccines
- (2008) Seppo Meri et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More